Edesa Biotech Inc (EDSA) Institutional Investor Snapshot (34 Funds, Q2 2026)

EDSA ranks #7177 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

EDSA is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

34 institutions disclose a position in EDSA, but none treat it as a major bet — even Velan Capital Investment Management LP, its most concentrated holder, allocates just 4.1% of its own portfolio to it.

Velan Capital Investment Management LP has added to its EDSA position for two straight quarters, increasing it by $5.8M to reach $6.7M today.

EDSA is down 0.4% today, but institutions show net buying of $10.1M this quarter — a divergence between today's price move and the underlying institutional flow.

EDSA reported a net loss of $14.1M over the trailing twelve months.

• Not yet profitable — net loss of $14.1M over the trailing twelve months
• Revenue declined 100.0% year over year
• Net income declined year over year, from -$5.9M to -$14.1M
• Operating cash flow was negative, using $7.3M in cash
• Current ratio of 10.67x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.09x equity — within a conventional range